You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】 恆指兩萬五再遇阻 即市美團、阿里好淡倉各有資金吸納 恆指牛68485 熊68061/ 美團牛60217 熊54909/ 阿里購17105 沽20606
阿思達克 08-05 10:47
市場關注美國國會就新一輪刺激方案的談判進展,道指隔晚收報26828點,升164點(或0.6%)。納指再創新高。恆指昨曾飆逾600點,高見25062點,收報24946點,升488點(或2%)。今早好淡爭持,一度重返25000點以上,其後調頭回落,由即市高位倒跌超過200點,回至24900點之下。恆指好倉(牛證及認購權證)昨淨流出逾1億港元(下同),恆指淡倉(熊證及認沽權證)同日淨流入逾1.8億元,反映投資者預期港股急漲過後將回落。昨日恆指牛證街貨重貨區為收回價24200至24299點,而熊證街貨重貨區為收回價25300至25399點。

ATMX中以美團點評(03690)近日表現最強,昨一度飆逾一成,高見221.6元,創上市新高,全日收升8.6%報218元,兩日累漲13.6%。有傳美團將開展新一輪叫車服務吸客計劃,在主要城市推出補貼。另外,市場繼續關注下周五恆指季檢,美團或成為恆指成份股新貴。美團今早好淡爭持,曾再觸及220元,即市留意可否繼續破頂。昨有超過14億元北水淨買入美團。輪證資金流方面,昨有逾2400萬元淨流出其好倉,淡倉同日則有近2600萬元淨流入。

阿里巴巴(09988)旗下螞蟻集團啟動A+H上市計劃,有傳最快下月上市集資合共300億美元,阿里昨高見255元,升幅3.8%,收市維持逾3%的升幅,報253.8元。投資者同樣憧憬阿里有望染藍,股份今早於上日收市價附近好淡爭持。昨分別有超過2200萬元和220萬元淨流入其好倉和淡倉。

舜宇光學(02382)被券商下調評級,昨逆市下跌1%,收報146元,結束兩日升勢,不過守穩各移動平均線。舜宇今早窄幅上落,高位重上147元。昨有逾130萬元淨流入其好倉,淡倉同日則有逾30萬元淨流出。

香港連續第二天新增新型肺炎確診個案降至雙位數字,本地地產股有追捧。新世界發展(00017)昨曾升穿39元,收升3.3%,報38.9元,一舉收復20天和250天線。股份今早一度回落逾1%,下試38元水平。昨有小量資金淨流入其淡倉。

瑞通相關認股證之選擇:

美團輕微價外、中短期購16017,行使價:250元,2021年1月到期,實際槓桿:4.8倍

美團輕微價外、中年期沽16844,行使價:190元,2021年2月到期,實際槓桿:3.7倍

阿里價外、中短期購17105,行使價:303.88元,2021年1月到期,實際槓桿:6.8倍

阿里輕微價外、中短期沽20606,行使價:218.8元,2020年12月到期,實際槓桿:6.2倍

舜光輕微價外、中短期購17345,行使價:168.98元,2021年1月到期,實際槓桿:4.5倍

舜光輕微價外、中短期沽21333,行使價:130.8元,2021年1月到期,實際槓桿:2.7倍

新發輕微價外、中短期購22032,行使價:42.64元,2020年12月到期,實際槓桿:7.4倍

國壽輕微價外、中短期購22441,行使價:20.78元,2020年11月到期,實際槓桿:7.3倍

國壽輕微價外、中短期沽24199,行使價:15.88元,2021年1月到期,實際槓桿:4.9倍

S金貼價、中年期購19709,行使價:1499元,2021年4月到期,實際槓桿:4.9倍

瑞通相關牛熊證之選擇:

恆指牛證68485,收回價:24230點,槓桿比率:34.2倍

恆指熊證68061,收回價:25690點,槓桿比率:24.9倍

美團牛證60217,收回價:196.2元,槓桿比率:8.3倍

美團熊證54909,收回價:236.81元,槓桿比率:9.2倍

阿里牛證60212,收回價:240.18元,槓桿比率:14.7倍

阿里熊證53072,收回價:279.99元,槓桿比率:8.5倍

舜光牛證56266,收回價:137.38元,槓桿比率:9.5倍

舜光熊證50258,收回價:163.8元,槓桿比率:6.8倍

騰訊牛證55778,收回價:522.18元,槓桿比率:13.7倍

騰訊熊證53778,收回價:583.88元,槓桿比率:15.2倍

小米牛證54643,收回價:14.259元,槓桿比率:9.4倍

小米熊證66316,收回價:16.88元,槓桿比率:7.7倍

重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account